Dianthus Therapeutics, Inc. /DE/ (DNTH) /
The profitability of Dianthus Therapeutics, Inc. /DE/ over the past 10 years
Chart Dianthus Therapeutics, Inc. /DE/: operating income, net income, fiscal 2016–2025 Open the chart →Dianthus Therapeutics, Inc. /DE/ reported a net loss of $162.34M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $177.93M. It reported a loss in all 10 years shown.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$177.93M | -$162.34M |
| 2024ended Dec 31, 2024 | -$101.86M | -$84.97M |
| 2023ended Dec 31, 2023 | -$48.17M | -$43.55M |
| 2022ended Dec 31, 2022 | -$29.7M | -$28.48M |
| 2021ended Dec 31, 2021 | -$74.69M | -$71.14M |
| 2020ended Dec 31, 2020 | -$78.7M | -$74.94M |
| 2019ended Dec 31, 2019 | -$82.97M | -$76.77M |
| 2018ended Dec 31, 2018 | -$59.96M | -$57.52M |
| 2017ended Dec 31, 2017 | -$35.73M | -$35.49M |
| 2016ended Dec 31, 2016 | -$9.27M | -$9.43M |
Fiscal years as Dianthus Therapeutics, Inc. /DE/ reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Dianthus Therapeutics, Inc. /DE/
- The revenue of Dianthus Therapeutics, Inc. /DE/
- The cash flow of Dianthus Therapeutics, Inc. /DE/
- The debt of Dianthus Therapeutics, Inc. /DE/
- All of Dianthus Therapeutics, Inc. /DE/'s financials, charted
Companies of a similar size
- EPREPR PROPERTIES
- PAYPaymentus Holdings, Inc.
- IESCIES Holdings, Inc.
- HRIHERC HOLDINGS INC.
- GNTXGENTEX CORPORATION
Not investment advice. This page shows what Dianthus Therapeutics, Inc. /DE/ filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.